UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 92 filers reported holding UNITY BIOTECHNOLOGY INC in Q1 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,599,000 | -51.3% | 1,094,998 | 0.0% | 0.49% | -44.8% |
| Q3 2021 | $3,285,000 | -35.3% | 1,094,998 | 0.0% | 0.88% | -13.0% |
| Q2 2021 | $5,081,000 | -22.7% | 1,094,998 | 0.0% | 1.01% | -32.8% |
| Q1 2021 | $6,570,000 | +14.5% | 1,094,998 | 0.0% | 1.51% | -37.2% |
| Q4 2020 | $5,738,000 | +51.4% | 1,094,998 | 0.0% | 2.40% | +31.5% |
| Q3 2020 | $3,789,000 | -80.1% | 1,094,998 | -50.0% | 1.82% | -73.5% |
| Q2 2020 | $19,009,000 | +49.7% | 2,189,998 | 0.0% | 6.87% | +10.2% |
| Q1 2020 | $12,702,000 | -19.6% | 2,189,998 | 0.0% | 6.24% | -22.1% |
| Q4 2019 | $15,790,000 | – | 2,189,998 | – | 8.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mayo Clinic | 1,571,981 | $7,294,000 | 8.07% |
| Invus Financial Advisors, LLC | 1,094,998 | $5,081,000 | 1.01% |
| Founders Fund V Management, LLC | 491,751 | $2,282,000 | 0.78% |
| Tibra Equities Europe Ltd | 80,700 | $374,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 205,882 | $955,000 | 0.11% |
| Hall Private Wealth Advisors | 18,500 | $86,000 | 0.06% |
| 20/20 Capital Management, Inc. | 42,840 | $199,000 | 0.05% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 64,789 | $301,000 | 0.05% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 759,918 | $3,526,000 | 0.02% |
| PDT Partners, LLC | 74,178 | $344,000 | 0.02% |